세계의 바이오의약품 용도 및 CQA 측정용 자동 샘플링 시장 : 모니터링 방법 유형, 바이오프로세스 방법, 작업량, 확장성, 주요 지역별 - 업계 동향과 예측(2022-2035년)

Automatic Sampling in Biopharmaceutical Applications and the Measurement of CQA: Distribution by Type of Monitoring Method, Bioprocessing Method, Working Volume, Scalability, Key Geographical Regions : Industry Trends and Global Forecasts, 2022-2035

US $ 4,799 ￦ 6,618,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,999 ￦ 9,653,000

PDF (One-Location Site License)

PDF 보고서를 동일 사업장의 특정 사업 부문에 속한 모든 분들이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,599 ￦ 14,618,000

PDF (Department License)

PDF 보고서를 부서 단위로 12명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 17,999 ￦ 24,824,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세계의 바이오의약품 용도·CQA 측정용 자동 샘플링 시장에 대해 조사분석했으며, 시장 구도, 부문 분석, 특허 분석, 기업 개요 등을 정리하여 전해드립니다.

목차

제1장 서문

제2장 개요

제3장 서론

제4장 시장 구도 : 자동 샘플링 시스템

• 챕터 개요
• 자동 샘플링 시스템 : 전체적인 시장 구도
• 자동 샘플링 시스템 제조업체의 리스트

제5장 기업 경쟁력 분석

• 챕터 개요
• 전제조건/주요 파라미터
• 범위와 조사 방법
• 기업 경쟁력 분석 : 북미의 자동 샘플링 시스템 제조업체
• 기업 경쟁력 분석 : 유럽의 자동 샘플링 시스템 제조업체
• 기업 경쟁력 분석 : 아시아태평양의 자동 샘플링 시스템 제조업체

제6장 기업 개요 : 자동 샘플링 시스템 제조업체

• 챕터 개요
• Agilent Technologies
• Cytiva
• Mettler Toledo
• Pall Corporation
• Shimadzu
• Xylem

제7장 시장 구도 : 자동 샘플 수집/조제 시스템

• 챕터 개요
• 자동 샘플 수집/조제 시스템 : 전체적인 시장 구도
• 자동 샘플 수집/조제 시스템 제조업체의 리스트

제8장 기업 개요 : 자동 샘플 수집/조제 시스템 제조업체

• 챕터 개요
• Agilent Technologies
• Biotage
• Flownamics
• MGI Tech
• SOTAX

제9장 특허 분석

• 챕터 개요
• 범위와 조사 방법
• 바이오의약품 용도·CQA 측정용 자동 샘플링 : 특허 분석
• 바이오의약품 용도·CQA 측정용 자동 샘플링 : 특허 벤치마킹 분석
• 바이오의약품 용도·CQA 측정용 자동 샘플링 : 특허 평가 분석
• 주요 특허 : 인용 수별

제10장 최근의 발전

• 챕터 개요
• 바이오의약품 용도·CQA 측정용 자동 샘플링 : 파트너십 활동
• 바이오의약품 용도·CQA 측정용 자동 샘플링 : 세계의 이벤트
• 결론

제11장 SWOT 분석

제12장 Porter의 산업 분석

제13장 시장 예측과 기회 분석

• 챕터 개요
• 주요 전제조건과 조사 방법
• 세계의 바이오의약품 용도·CQA 측정용 자동 샘플링 시장(2022-2035년)

제14장 인더스트리 1.0으로부터 인더스트리 5.0으로의 산업혁명

• 챕터 개요
• 인더스트리 1.0으로부터 인더스트리 5.0로의 이동
• 랩 진화의 지평
• 인더스트리 4.0의 이점
• 인더스트리 5.0의 이점
• 결론

제15장 결론

제16장 이그제큐티브 인사이트

제17장 부록 1 : 데이터 표

제18장 부록 2 : 기업과 조직 리스트

KSA

영문 목차

영문목차

INTRODUCTION

During each stage of biopharmaceutical manufacturing process, it is essential to ensure that the bioprocess variables and parameters are under control. Sampling is considered to be an important step in the bioprocess. However, there are several challenges associated with conventional, manual aseptic sampling technique, such as high risk of contamination of the sample, high labor costs, operator-to-operator deviations during sampling and sample preparation, lower sample frequency rates and no real-time availability of data. This has created a demand for systems that allow aseptic sampling and handling of samples, reduce errors, and increase reproducibility. As a result, automatic sampling systems have emerged to be the most appropriate solution as these systems have the potential to address a number of challenges associated with manual sampling method and offer various additional benefits including real-time data monitoring, reduction in deviations by around 65% and increase in the overall productivity up to 80%. Moreover, automated sampling systems ensure that the processes continue to run within precise limits and make the necessary adjustments, while minimizing the risk of human errors, improving the overall product quality, timely monitoring critical process parameters, bringing tangible cost benefits and increased throughput.

Several companies are actively engaged in the manufacturing of automatic sampling systems and automatic sample preparation systems that can be used across various scale of operations in biopharmaceutical manufacturing. These systems have diverse applications, including bioprocess / analyte monitoring, fraction collection, data management and advanced process control / feedback control in biotechnology, pharmaceutical, chemical, food and cosmetic industries. In addition, automatic sampling systems use process analytical technology (PAT) that can be easily integrated in the bioprocessing unit in order to improve scalability. Further, the field has witnessed several innovations, constantly evolving guidelines for pharmaceutical bioprocessing, mainly based on automation, digitalization and process transparency. It is also important to highlight that several equipment manufacturers offering user-friendly, controlled, and automated systems, have recently emerged. Given the rising interest of stakeholders towards technological advancements and adoption of these systems, we believe that the overall market for automatic sampling in biopharmaceutical applications and the measurement of CQA is anticipated to witness substantial growth in the coming years.

SCOPE OF THE REPORT

The 'Automatic Sampling in Biopharmaceutical Applications and the Measurement of CQA, 2022-2035: Distribution by Type of Monitoring Method (On-line, Off-line and At-line), Bioprocessing Method (Upstream and Downstream), Working Volume (Less than 10 mL, 10-50 mL, 51-100 mL and more than 100 mL), Scalability (Lab Scale, Pilot Scale and Commercial Scale), Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts, 2022-2035' report features an extensive study on the current and future potential of automatic sampling systems. Due to the growing demand for biologics and stringent regulatory guidelines, the biopharmaceutical industry has shifted to using automatic sampling methods, which offer reliable systems for transferring bioprocess samples directly from bioreactors to analytical devices while maintaining the process sterility and integrity. In addition, it features an elaborate discussion on the likely opportunity for the players engaged in this domain, over the next decade. Amongst other elements, the report includes:

• A detailed assessment of the current market landscape of automatic sampling systems, featuring a detailed analysis of these systems based on several parameters, such as type of monitoring method, type of sampling unit(s), availability of pump / probe, type of module, automated software, type of vessel, vessel fabrication material, type of analyte monitored, type of analyzer, number of sampling vessels, working volume, operating temperature, end user industry, scalability and applications of the system. In addition, the chapter includes analysis of automatic sampling system developers, along with information on their year of establishment, company size, location of headquarters and leading players (in terms of number of systems being offered).

• A competitiveness analysis of automatic sampling systems manufacturers based on various relevant parameters, such as overall experience of the company (in terms of number of years since it was established), product portfolio strength (in terms of number of automatic sampling systems manufactured and type of monitoring method) and portfolio diversity (in terms of type of sampling unit, end user industry, scalability and applications).

• Elaborate profiles of prominent players engaged in this domain. Each profile includes a brief overview of the company, details related to its financial information (if available), information on product portfolio, recent developments and an informed future outlook.

• A detailed market landscape of automatic sample collection / preparation systems, based on a several relevant parameters, such as system category, system classification, type of monitoring method, type of sampling unit, type of module, working volume, type of analyzer, end user industry and scalability of the products. In addition, the chapter includes a list of players engaged in developing automatic sample collection / preparation systems along with information on their year of establishment, company size, location of headquarters. Further, it also highlights the leading manufacturers of automatic sample collection / preparation systems (in terms of the number of systems manufactured).

• Detailed profiles of the players offering automatic sample collection / preparation systems. It includes a brief overview of the company, details of its product portfolio, and a section on recent developments and an informed future outlook.

• An insightful analysis of the patents filed / granted for automatic sampling systems, since 2016, taking into consideration various relevant parameters, such as type of patent, publication year, geographical location, CPC symbols, emerging focus areas, type of organization, leading players (in terms of number of patents granted / filed in the given time period) and patent characteristics. In addition, the chapter includes a detailed patent benchmarking and an insightful valuation analysis.

• An analysis of various developments / recent trends related to automatic sampling systems, offering insights on recent global events related to automatic sampling systems, and partnerships and collaborations established within the industry.

• A discussion on affiliated trends, key drivers and challenges, under a SWOT framework, featuring a Harvey ball analysis, highlighting the relative impact of each SWOT parameter on the overall automatic sampling systems market.

• A qualitative analysis, highlighting the five competitive forces prevalent in this domain, including threats of new entrants, bargaining power of customers, bargaining power of automatic sampling system manufacturers, threats of substitute products and rivalry among existing competitors.

One of the key objectives of the report was to estimate the existing market size and the future opportunity for automatic sampling systems, over the coming 13 years. We have provided informed estimates of the likely evolution of the market in the short to mid-term and long term, for the period 2022-2035. Our year-wise projections of the current and future opportunity have further been segmented based on relevant parameters, such as type of monitoring method (on-line, off-line and at-line), bioprocessing method (upstream and downstream), working volume (less than 10 ml, 10-50 ml, 51-100 ml and more than 100 ml), scalability (lab scale, pilot scale and commercial scale), and key geographical regions (North America, Europe, Asia-Pacific and Rest of the World). In order to account for future uncertainties and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry's growth.

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.

RESEARCH METHODOLOGY

The data presented in this report has been gathered via secondary and primary research. For all our projects, we conduct interviews with experts in the area (academia, industry and other associations) to solicit their opinions on emerging trends in the market. The information is primarily useful for us to draw out our opinion on how the market will evolve across different regions and technology segments. Wherever possible, the available data has been validated from multiple sources of information.

The secondary sources of information include:

• Annual reports
• Investor presentations
• SEC filings
• Industry databases
• News releases from company websites
• Government policy documents
• Industry analysts' views

While the focus has been on forecasting the market till 2035, the report also provides our independent views on various non-commercial trends emerging in the industry. This opinion is solely based on our knowledge, research and understanding of the relevant market gathered from various secondary and primary sources of information.

KEY QUESTIONS ANSWERED

• Who are the key players engaged in the development of automatic sampling systems?

• What is the relative competitiveness of different automatic sampling system manufacturers?

• Who are the leading manufacturers involved in the automatic sample collection / preparation systems?

• How has the intellectual property landscape in this domain evolved over the years?

• What are the key agenda items being discussed in various global events / conferences held in this domain?

• Which partnership models are most commonly adopted by stakeholders engaged in this industry?

• How is the current and future market opportunity, likely to be distributed across key market segments?

CHAPTER OUTLINES

• Chapter 2 is an executive summary of the key insights captured in our research. It offers a high-level view on the current state of the automatic sampling systems market and its likely evolution in the short-mid to long term.

• Chapter 3 provides a brief overview of automatic sampling systems and process analytical technology (PAT) in sampling. Additionally, it features comparison between manual and automatic sampling, need for automatic sampling systems, components of a sampling system, stand-alone versus integrated systems, monitoring methods for critical process parameters and quality attributes, key considerations for automatic sampling and benefits of these systems to biopharmaceutical players. Further, it also highlights the future perspectives in this domain.

• Chapter 4 presents an overview of the current market landscape of automatic sampling systems, featuring a detailed analysis of these systems based on several parameters, such as type of monitoring method, type of sampling unit(s), availability of pump / probe, type of module, automated software, type of vessel, vessel fabrication material, type of analyte monitored, type of analyzer, number of sampling vessels, working volume, operating temperature, end user industry, scalability and applications of the system. In addition, the chapter includes analysis of automatic sampling system developers, along with information on their year of establishment, company size, location of headquarters and leading players (in terms of number of systems being offered).

• Chapter 5 provides a competitiveness analysis of automatic sampling systems manufacturers based on various relevant parameters, such as overall experience of the company (in terms of number of years since it was established), product portfolio strength (in terms of number of automatic sampling systems manufactured and type of monitoring method) and portfolio diversity (in terms of type of sampling unit, end user industry, scalability and applications).

• Chapter 6 includes profiles of the key players engaged in the development of automatic sampling systems (shortlisted on the basis of the company size). Each profile features a brief overview of the company, its financial information (if available), details on its product portfolio, recent developments and an informed future outlook.

• Chapter 7 presents an overview of the current market landscape of automatic sample collection / preparation systems, based on a several relevant parameters, such as system category, system classification, type of system, type of monitoring method, type of sampling unit, type of module, working volume, type of analyzer, end user industry and scalability of the products. In addition, the chapter includes a list of players engaged in developing automatic sample collection / preparation systems along with information on their year of establishment, company size, location of headquarters. Further, it also highlights the leading manufacturers of automatic sample collection / preparation systems (in terms of the number of systems manufactured).

• Chapter 8 includes profiles of the key players engaged in the development of automatic sample collection / preparation systems (shortlisted on the basis of the number of systems manufactured). Each profile features a brief overview of the company, details on its product portfolio, recent developments and an informed future outlook.

• Chapter 9 features an in-depth analysis of the patents that have been filed / granted for the automatic sampling systems, since 2016. The analysis also highlights the key trends associated with the patents, such as the type of patent (granted patent, patent application and others), publication year, annual number of granted patents and patent applications, geographical location, CPC symbols, emerging focus areas of the patents, type of organization and leading players (in terms of number of patents granted / filed). In addition, it includes detailed patent benchmarking and valuation analysis based on patent characteristics.

• Chapter 10 features analyses of instances wherein companies have entered into partnerships with other stakeholders related to automatic sampling in biopharmaceutical applications and the measurement of CQA and recent events (conferences / seminars / symposiums / webinars / workshops) that were organized by several stakeholders engaged in this domain.

• Chapter 11 provides information on the affiliated trends, key drivers and challenges associated with automatic sampling systems, under a reliable SWOT framework. The chapter includes a Harvey ball analysis, highlighting the relative impact of each SWOT parameter on the overall automatic sampling systems market.

• Chapter 12 provides insights on a qualitative analysis highlighting five competitive forces in this domain, including threats of new entrants, bargaining power of customers, bargaining power of automatic sampling system manufacturers, threats of substitute products and rivalry among existing competitors.

• Chapter 13 features a detailed market forecast of the likely growth of automatic sampling systems, till the year 2035. It also includes insights on the likely distribution of the current and forecasted opportunity across the type of monitoring method (on-line, off-line and at-line), bioprocessing method (upstream and downstream), working volume (less than 10 ml, 10-50 ml, 51-100 ml and more than 100 ml), scalability (lab scale, pilot scale and commercial scale), and key geographical regions (North America, Europe, Asia-Pacific and Rest of the World).

• Chapter 14 presents a discussion about the transition of biopharmaceutical industry from 1.0 to 5.0, highlighting different horizons of laboratory evolution. Further, it presents the comparison between Industry 4.0 and Industry 5.0.

• Chapter 15 is a summary of the overall report, presenting insights on the contemporary market trends and the likely evolution of the automatic sampling systems market.

• Chapter 16 provides the transcripts of the interviews conducted with senior representatives of renowned organizations that are engaged in the automatic sampling domain.

• Chapter 17 is an appendix, that contains tabulated data and numbers for all the figures provided in the report.

• Chapter 18 is an appendix, that contains the list of companies and organizations mentioned in the report.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Scope of the Report
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Key Questions Answered
• 1.5. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

• 3.1. Chapter Overview
• 3.2. Process Analytical Technology in Sampling
• 3.3. Manual Sampling versus Automatic Sampling
• 3.4. Need for Automatic Sampling Systems
• 3.5. Automatic Aseptic Sampling System
• 3.6. Components of a Sampling System
• 3.7. Stand-alone Systems versus Integrated Systems
• 3.8. Bioprocess Monitoring and Control Methods
  • 3.8.1. At-line Monitoring
  • 3.8.2. In-line Monitoring
  • 3.8.3. Off-line Monitoring
  • 3.8.4. On-line Monitoring
• 3.9. Key Considerations for Automatic Sampling
  • 3.9.1. Sample Volume
  • 3.9.2. Cell Removal
  • 3.9.3. Sampling Rate
  • 3.9.4. Integration of Analyzers
  • 3.9.5. Feedback to Bioreactor
  • 3.9.6. Flexibility
  • 3.9.7. Transferability
  • 3.9.8. Price
• 3.10. Benefits of Automatic Sampling Systems
• 3.11. Standards and Requirements
• 3.12. Future Innovations

4. MARKET LANDSCAPE: AUTOMATIC SAMPLING SYSTEMS

• 4.1. Chapter Overview
• 4.2. Automatic Sampling Systems: Overall Market Landscape
  • 4.2.1. Analysis by Type of Monitoring Method
  • 4.2.2. Analysis by Type of Sampling Unit
  • 4.2.3. Analysis by Availability of Pump / Probe
  • 4.2.4. Analysis by Type of Module
  • 4.2.5. Analysis by Automated Software
  • 4.2.6. Analysis by Type of Vessel
  • 4.2.7. Analysis by Vessel Fabrication Material
  • 4.2.8. Analysis by Type of Analyte Monitored
  • 4.2.9. Analysis by Type of Analyzer
  • 4.2.10. Analysis by Number of Sampling Vessels
  • 4.2.11. Analysis by Working Volume
  • 4.2.12. Analysis by Operating Temperature
  • 4.2.13. Analysis by End User Industry
  • 4.2.14. Analysis by Scalability
  • 4.2.15. Analysis by Application(s)
• 4.3. List of Automatic Sampling System Manufacturers
  • 4.3.1. Analysis by Year of Establishment
  • 4.3.2. Analysis by Company Size
  • 4.3.3. Analysis by Region of Headquarters
  • 4.3.4. Analysis by Company Size and Region of Headquarters
  • 4.3.5. Analysis by Location of Headquarters
  • 4.3.6. Leading Players: Analysis by Number of Automatic Sampling Systems Manufactured
  • 4.2.7. Leading Automatic Sampling System Manufacturers: Analysis by Number of End User Industries

5. COMPANY COMPETITIVENESS ANALYSIS

• 5.1. Chapter Overview
• 5.2. Assumptions / Key Parameters
• 5.3. Scope and Methodology
• 5.4. Company Competitiveness Analysis: Automatic Sampling System Manufacturers in North America
• 5.5. Company Competitiveness Analysis: Automatic Sampling System Manufacturers in Europe
• 5.6. Company Competitiveness Analysis: Automatic Sampling System Manufacturers in Asia-Pacific

6. COMPANY PROFILES: AUTOMATIC SAMPLING SYSTEM MANUFACTURERS

• 6.1. Chapter Overview
• 6.2. Agilent Technologies
  • 6.2.1. Company Overview
  • 6.2.2. Financial Information
  • 6.2.3. Product Portfolio
  • 6.2.4. Recent Developments and Future Outlook
• 6.3. Cytiva
  • 6.3.1. Company Overview
  • 6.3.2. Product Portfolio
  • 6.3.3. Recent Developments and Future Outlook
• 6.4. Mettler Toledo
  • 6.4.1. Company Overview
  • 6.4.2. Financial Information
  • 6.4.3. Product Portfolio
  • 6.4.4. Recent Developments and Future Outlook
• 6.5. Pall Corporation
  • 6.5.1. Company Overview
  • 6.5.2. Product Portfolio
  • 6.5.3. Recent Developments and Future Outlook
• 6.6. Shimadzu
  • 6.6.1. Company Overview
  • 6.6.2. Financial Information
  • 6.6.3. Product Portfolio
  • 6.6.4. Recent Developments and Future Outlook
• 6.7. Xylem
  • 6.7.1. Company Overview
  • 6.7.2. Financial Information
  • 6.7.3. Product Portfolio
  • 6.7.4. Recent Developments and Future Outlook

7. MARKET LANDSCAPE: AUTOMATIC SAMPLE COLLECTION / PREPARATION SYSTEMS

• 7.1. Chapter Overview
• 7.2. Automatic Sample Collection / Preparation Systems: Overall Market Landscape
  • 7.2.1. Analysis by System Category
  • 7.2.2. Analysis by System Classification
  • 7.2.3. Analysis by Type of Monitoring Method
  • 7.2.4. Analysis by Type of Sampling Unit
  • 7.2.5. Analysis by Type of Module
  • 7.2.6. Analysis by Working Volume
  • 7.2.7. Analysis by Type of Analyzer
  • 7.2.8. Analysis by End User Industry
  • 7.2.9. Analysis by Scalability
• 7.3. List of Automatic Sample Collection / Preparation System Manufacturers
  • 7.3.1. Analysis by Year of Establishment
  • 7.3.2. Analysis by Company Size
  • 7.3.3. Analysis by Region of Headquarters
  • 7.3.4. Analysis by Company Size and Region of Headquarters
  • 7.3.5. Analysis by Location of Headquarters
  • 7.3.6. Leading Players: Analysis by Number of Automatic Sample Collection / Preparation Systems Manufactured

8. COMPANY PROFILES: AUTOMATIC SAMPLE COLLECTION / PREPARATION SYSTEM MANUFACTURERS

• 8.1. Chapter Overview
• 8.2. Agilent Technologies
  • 8.2.1. Company Overview
  • 8.2.2. Product Portfolio
  • 8.2.3. Recent Developments and Future Outlook
• 8.3. Biotage
  • 8.3.1. Company Overview
  • 8.3.2. Product Portfolio
  • 8.3.3. Recent Developments and Future Outlook
• 8.4. Flownamics
  • 8.4.1. Company Overview
  • 8.4.2. Product Portfolio
  • 8.4.3. Recent Developments and Future Outlook
• 8.5. MGI Tech
  • 8.5.1. Company Overview
  • 8.5.2. Product Portfolio
  • 8.5.3. Recent Developments and Future Outlook
• 8.6. SOTAX
  • 8.6.1. Company Overview
  • 8.6.2. Product Portfolio
  • 8.6.3. Recent Developments and Future Outlook

9. PATENT ANALYSIS

• 9.1. Chapter Overview
• 9.2. Scope and Methodology
• 9.3. Automatic Sampling in Biopharmaceutical Applications and the Measurement of CQA: Patent Analysis
  • 9.3.1. Analysis by Publication Year
  • 9.3.2. Analysis by Annual Number of Granted Patents and Patent Applications
  • 9.3.3. Analysis by Geographical Location
  • 9.3.4. Analysis by CPC Symbols
  • 9.3.5. Word Cloud: Emerging Focus Areas
  • 9.3.6. Analysis by Type of Organization
  • 9.3.7. Leading Industry Players: Analysis by Number of Patents
  • 9.3.8. Leading Non-Industry Players: Analysis by Number of Patents
  • 9.3.9. Leading Individual Assignees: Analysis by Number of Patents
• 9.4. Automatic Sampling in Biopharmaceutical Applications and the Measurement of CQA: Patent Benchmarking Analysis
  • 9.4.1. Analysis by Patent Characteristics
• 9.5. Automatic Sampling in Biopharmaceutical Applications and the Measurement of CQA: Patent Valuation Analysis
• 9.6. Leading Patents by Number of Citations

10. RECENT DEVELOPMENTS

• 10.1. Chapter Overview
• 10.2. Automatic Sampling in Biopharmaceutical Applications and the Measurement of CQA: Partnership Activity
  • 10.2.1. Partnership Models
  • 10.2.2. List of Partnerships and Collaborations
    • 10.2.2.1. Analysis by Year of Partnership
    • 10.2.2.2. Analysis by Type of Partnership
    • 10.2.2.3. Analysis by Type of Product
    • 10.2.2.4. Analysis by Product and Type of Partnership
    • 10.2.2.5. Most Active Players: Analysis by Number of Partnerships
    • 10.2.2.6. Word Cloud: Emerging Focus Areas
    • 10.2.2.7. Regional Analysis
    • 10.2.2.8. Intercontinental and Intracontinental Agreements
• 10.3. Automatic Sampling in Biopharmaceutical Applications and the Measurement of CQA: Global Events
  • 10.3.1. List of Global Events
    • 10.3.1.1. Analysis by Year of Event
    • 10.3.1.2. Analysis by Event Platform
    • 10.3.1.3. Analysis by Type of Event
    • 10.3.1.4. Analysis by Geography
    • 10.3.1.5. Word Cloud: Evolutionary Trends in Event Agenda / Key Focus Area
    • 10.3.1.6. Most Active Participants: Analysis by Number of Events
    • 10.3.1.7. Analysis by Seniority Level of Event Speakers
• 10.4. Concluding Remarks

11. SWOT ANALYSIS

• 11.1. Chapter Overview
• 11.2. Automatic Sampling in Biopharmaceutical Applications and the Measurement of CQA: SWOT Analysis
  • 11.2.1. Comparison of SWOT Factors

12. PORTERS FIVE FORCES ANALYSIS

• 12.1. Chapter Overview
• 12.2. Methodology and Assumptions
• 12.3. Key Parameters
  • 12.3.1. Threats of New Entrants
  • 12.3.2. Bargaining Power of Customers
  • 12.3.3. Bargaining Power of Automatic Sampling System Manufacturers
  • 12.3.4. Threats of Substitute Products
  • 12.3.5. Rivalry Among Existing Competitors
• 12.4. Concluding Remarks

13. MARKET FORECAST AND OPPORTUNITY ANALYSIS

• 13.1. Chapter Overview
• 13.2. Key Assumptions and Methodology
• 13.3. Global Automatic Sampling in Biopharmaceutical Applications and the Measurement of CQA Market, 2022-2035
  • 13.3.1. Automatic Sampling in Biopharmaceutical Applications and the Measurement of CQA Market, 2022 and 2035: Distribution by Type of Monitoring Method
    • 13.3.1.1. Automatic Sampling Market for On-line Monitoring, 2022-2035
    • 13.3.1.2. Automatic Sampling Market for Off-line Monitoring, 2022-2035
    • 13.3.1.3. Automatic Sampling Market for At-line Monitoring, 2022-2035
  • 13.3.2. Automatic Sampling in Biopharmaceutical Applications and the Measurement of CQA Market, 2022 and 2035: Distribution by Type of Bioprocessing Method
    • 13.3.2.1. Automatic Sampling Market for Upstream Bioprocessing, 2022-2035
    • 13.3.2.2. Automatic Sampling Market for Downstream Bioprocessing, 2022-2035
  • 13.3.3. Automatic Sampling in Biopharmaceutical Applications and the Measurement of CQA Market, 2022 and 2035: Distribution by Working Volume
    • 13.3.3.1. Automatic Sampling Market for Systems with less than 10 mL Working Volume, 2022-2035
    • 13.3.3.2. Automatic Sampling Market for Systems with 10-50 mL Working Volume, 2022-2035
    • 13.3.3.3. Automatic Sampling Market for Systems with 51-100 mL Working Volume, 2022-2035
    • 13.3.3.4. Automatic Sampling Market for Systems with more than 100 mL Working Volume, 2022-2035
  • 13.3.4. Automatic Sampling in Biopharmaceutical Applications and the Measurement of CQA Market, 2022 and 2035: Distribution by Scalability
    • 13.3.4.1. Automatic Sampling Market for Lab Scale Operations, 2022-2035
    • 13.3.4.2. Automatic Sampling Market for Pilot Scale Operations, 2022-2035
    • 13.3.4.3. Automatic Sampling Market for Commercial Scale Operations, 2022 2035
  • 13.3.5. Automatic Sampling in Biopharmaceutical Applications and the Measurement of CQA Market, 2022 and 2035: Distribution by Key Geographical Regions
    • 13.3.5.1. Automatic Sampling Market in North America, 2022-2035
    • 13.3.5.2. Automatic Sampling Market in Europe, 2022-2035
    • 13.3.5.3. Automatic Sampling Market in Asia-Pacific and Rest of the World, 2022 2035

14. INDUSTRIAL REVOLUTION FROM INDUSTRY 1.0 TO INDUSTRY 5.0

• 14.1. Chapter Overview
• 14.2. Transition from Industry 1.0 to Industry 5.0
  • 14.2.1. Industry 1.0
  • 14.2.2. Industry 2.0
  • 14.2.3. Industry 3.0
  • 14.2.4. Industry 4.0
  • 14.2.5. Industry 5.0
• 14.3. Horizons of Lab Evolution
• 14.4. Benefits of Industry 4.0
• 14.5. Benefits of Industry 5.0
• 14.6. Concluding Remarks

15. CONCLUDING REMARKS

16. EXECUTIVE INSIGHTS

17. APPENDIX 1: TABULATED DATA

18. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

관련자료